Skip to the page

Data / Form D filings / ENDOSTIM, INC.

ENDOSTIM, INC.: Form D filings

ENDOSTIM, INC., a health care company in Dallas, TX, filed 15 Form D notices with the SEC between 2009 and 2018. The latest, on December 31, 2018, reports $2.8 million sold of a $7 million offering to 4 investors.

Find out what ENDOSTIM, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4104 McEwen Drive, SUITE 336, Dallas, TX, 75244
Phone
(469) 680-3090
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1469166

The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 31, 2018New notice$7,000,000$2,808,000$4,192,0004Dec 17, 2018sec.gov
Jan 16, 2018Amendment$25,000,000$12,149,119$12,850,88120Dec 28, 2017sec.gov
Jan 12, 2018New notice$25,000,000$12,149,119$12,850,88120Dec 28, 2017sec.gov
Mar 23, 2016New notice$20,000,000$11,063,742$8,936,25883Mar 10, 2016sec.gov
May 8, 2015New notice$4,999,995$2,500,003$2,499,9921May 7, 2015sec.gov
Jul 10, 2014New notice$7,500,000$6,364,780$1,135,22072Jun 25, 2014sec.gov
May 29, 2013Amendment$16,500,000$14,080,174$2,419,82681Dec 5, 2012sec.gov
Apr 23, 2013Amendment$16,500,000$12,754,916$3,745,08472Dec 5, 2012sec.gov
Mar 19, 2013Amendment$16,500,000$11,210,074$5,289,92667Dec 5, 2012sec.gov
Jan 14, 2013Amendment$12,000,000$9,133,808$2,866,19256Dec 5, 2012sec.gov
Dec 14, 2012New notice$12,000,000$8,158,155$3,841,84541Dec 5, 2012sec.gov
Dec 5, 2011New notice$5,548,991$5,548,991$010Nov 22, 2011sec.gov
Jul 30, 2010New notice$6,000,000$5,999,926$7426Jul 13, 2010sec.gov
Oct 1, 2009New notice$945,000$775,000$170,00016Sep 18, 2009sec.gov
Jul 28, 2009New notice$600,000$550,000$50,0006Jul 13, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Brian D. FarleyDirector
Paul V. GoodeExecutive Officer
Alexander V. SchmitzDirector
Virender K. SharmaExecutive Officer
Douglas D. FrenchDirector

Other health care companies in Texas that filed recently

Every Form D from the week of Dec 31, 2018 · All recent filings in Texas · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ENDOSTIM, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.